Renger John

Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc.

Sold, on record
$16.1M
Dollars the filings state
Form 4 sales
17
Latest Feb 7, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. Apr 13, 2022 2022

    Sold 45,000 shares at $34.65 ($1.6M)

    Renger John, Chief Scientific Officer

    Sold 95.8% of holdings ($1.6M position)1,980 shares left1.8x usual sizeFiling

  2. Jul 6, 2022 +84 days

    Sold 26,105 shares at $30.11 ($786k)

    Renger John, Chief Scientific Officer

    Sold 90.6% of holdings ($867k position)2,704 shares left0.9x usual sizeFiling

  3. Jul 20, 2022 +14 days

    Sold 25,000 shares at $30.00 ($750k)

    Renger John, Chief Scientific Officer

    Sold 90.2% of holdings ($831k position)2,704 shares left1x usual sizeFiling

  4. Aug 8, 2022 +19 days

    Sold 30,000 shares at $34.25 ($1M)

    Renger John, Chief Scientific Officer

    Sold 91.7% of holdings ($1.1M position)2,704 shares left1.2x usual sizeFiling

  5. Aug 10, 2022 +2 days

    Sold 55,000 shares at $40.50 ($2.2M)

    Renger John, Chief Scientific Officer

    Sold 95.3% of holdings ($2.3M position)2,704 shares left2.1x usual sizeFiling

  6. Oct 4, 2022 +55 days

    Sold 25,000 shares at $30.00 ($750k)

    Renger John, Chief Scientific Officer

    Sold 90.2% of holdings ($831k position)2,704 shares left0.9x usual sizeFiling

  7. Nov 1, 2022 +28 days

    Sold 25,000 shares at $30.00 ($750k)

    Renger John, Chief Scientific Officer

    Sold 90.2% of holdings ($831k position)2,704 shares left1x usual sizeFiling

  8. Feb 7, 2024 +463 days

    Sold 2,161 shares at $41.54 ($90k)

    Renger John, Chief Scientific Officer

    No 10b5-1 planSold 25.3% of holdings ($354k position)6,370 shares left0.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by Renger John
Source
Feb 7, 2024Feb 8, 2024Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale2,161$90k25.3%UnusualSEC
Nov 1, 2022Nov 3, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale25,000$750k90.2%UnusualSEC
Oct 4, 2022Oct 6, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale25,000$750k90.2%UnusualSEC
Aug 10, 2022Aug 12, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale55,000$2.2M95.3%UnusualSEC
Aug 8, 2022Aug 9, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale30,000$1M91.7%UnusualSEC
Jul 20, 2022Jul 22, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale25,000$750k90.2%UnusualSEC
Jul 6, 2022Jul 7, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale26,105$786k90.6%UnusualSEC
Apr 13, 2022Apr 15, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale45,000$1.6M95.8%UnusualSEC
Mar 29, 2022Mar 31, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale10,000$350k83.5%UnusualSEC
Mar 18, 2022Mar 18, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale45,000$1.4M95.8%UnusualSEC
Mar 9, 2022Mar 11, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale30,000$1M93.8%UnusualSEC
Mar 2, 2022Mar 4, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale25,000$750k92.7%UnusualSEC
Feb 9, 2022Feb 11, 2022Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale25,000$750k92.7%UnusualSEC
Dec 27, 2021Dec 28, 2021Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale10,000$350k83.5%UnusualSEC
Dec 21, 2021Dec 23, 2021Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale7,300$237k78.7%UnusualSEC
Dec 17, 2021Dec 17, 2021Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale37,700$1.2M95.0%UnusualSEC
Nov 10, 2021Nov 15, 2021Cerevel Therapeutics Holdings, Inc.Chief Scientific OfficerForm 4 sale55,000$2.2M100.0%UnusualSEC